ANGPTL4 and hepatocellular carcinoma: High levels of ANGPTL4 are associated with a poor prognosis in solid tumors, such as prostate cancer, melanoma, hepatocellular carcinoma, bladder cancer, scirrhous gastric cancer, giant cell tumor, oral tongue cancer, and tongue squamous cell carcinoma [80–88].